Mental Health Drug Company Prepares for IPO
ATAI Life Sciences, a biopharmaceutical company developing psychedelic drugs, is going public on the Nasdaq. Learn more about the company’s IPO plans.
Read moreATAI Life Sciences, a biopharmaceutical company developing psychedelic drugs, is going public on the Nasdaq. Learn more about the company’s IPO plans.
Read moreThe EU wants to ban the use of facial recognition by police and some AI systems. Learn why the bloc is proposing these rules.
Read moreLithium mining deal making is heating up. Learn why Orocobre and Galaxy Resources are merging in a $3 billion deal.
Read moreNetflix’s subscriber growth is declining as pandemic restrictions start to ease and competition heats up. Learn more here.
Read moreLearn more about Apple’s recent product launch and its conflicts with Epic Games, Facebook, and lawmakers.
Read more